A Real-World Study of Upadacitinib in Anti-TNF Refractory Crohn's Disease - Dove Medical Press
This study looks at upadacitinib in people with Crohn’s disease who did not respond to anti-TNF drugs — a common and challenging clinical situation.
Tests and monitoring tools
CRP
CRP articles covering C-reactive protein blood testing, inflammation monitoring, treatment response, and IBD research. Monitoring context emphasizes diagnosis, follow-up, disease activity, treatment response, and care decisions.
2 articles
Phase 2 Trial: Ventyx's VTX958 Shows Strong Endoscopic Response in Crohn's Disease ...
New oral TYK2 inhibitor data show promise on endoscopic healing and inflammatory markers in Crohn’s disease, which is important because oral treatment options are limited. However, the trial missed its main symptom-based...